Related Experiment Video
Updated: Feb 13, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
[Clinical overview of auto-inflammatory diseases]
S Georgin-Lavialle1, F Rodrigues2, V Hentgen3
1Service de médecine interne, université Paris 6, Pierre-et-Marie-Curie (UPMC), hôpital Tenon, Assistance publique-Hôpitaux de Paris (AP-HP), 20, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, université Pierre-et-Marie-Curie (UPMC)-Paris 6, hôpital Trousseau, Assistance publique-Hôpitaux de Paris, 75012 Paris, France; Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France.
Monogenic auto-inflammatory diseases involve genetic defects in innate immunity, causing inflammatory crises without infection. Recent genetic advances have revealed numerous new conditions, expanding our understanding of these disorders.
Area of Science:
- Immunology
- Genetics
- Internal Medicine
Background:
- Monogenic auto-inflammatory diseases are genetic disorders affecting innate immunity proteins.
- They present with recurrent inflammatory episodes, distinct from autoimmune diseases due to the absence of autoantibodies.
- Key examples include familial Mediterranean fever and cryopyrinopathies, often mediated by interleukins.
Purpose of the Study:
- To provide a comprehensive overview of currently known monogenic auto-inflammatory diseases.
- To discuss the physiopathological classification based on interleukin and interferon pathways.
- To highlight recent discoveries driven by advancements in genetic analysis.
Main Methods:
- Literature review of monogenic auto-inflammatory diseases.
- Classification based on underlying molecular pathways (interleukin-1, interferon).
- Inclusion of polygenic inflammatory conditions like Still disease and Schnitzler syndrome.
Main Results:
- Auto-inflammatory diseases exhibit diverse clinical patterns, including recurrent fevers, chronic inflammation, and associated immunodeficiencies.
- A clear distinction is made between interleukin-1-mediated and interferon-mediated conditions.
- Polygenic inflammatory diseases such as Still disease, Schnitzler syndrome, and aseptic abscesses syndrome are also discussed.
Conclusions:
- Diagnosis relies on clinical presentation (anamnesis, inflammatory attacks) and increasingly sophisticated genetic testing.
- The field has expanded significantly due to genetic discoveries in the last decade.
- Understanding these diseases is crucial for accurate diagnosis and management.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Clinical Trials: Overview
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

